Evidence map›Paper›PMID 35682722›Full record

ReviewInternational journal of molecular sciences2022

Muscle Wasting in Chronic Kidney Disease: Mechanism and Clinical Implications-A Narrative Review.

Tsai-Chin Cheng, Shou-Hsien Huang, Chung-Lan Kao, Po-Cheng Hsu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Adverse Muscle Composition Is Associated with All-Cause Mortality in CKD: A UK Biobank Imaging Study.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Tsai-Chin ChengDepartment of Physical Medicine and Rehabilitation, Taipei Veterans General Hospital, Taipei 112, Taiwan.ORCID 0000-0003-1036-787X
Shou-Hsien HuangDepartment of Physical Medicine and Rehabilitation, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan.
Chung-Lan KaoDepartment of Physical Medicine and Rehabilitation, Taipei Veterans General Hospital, Taipei 112, Taiwan.ORCID 0000-0002-6803-4499
Po-Cheng HsuDepartment of Physical Medicine and Rehabilitation, Taipei Veterans General Hospital, Taipei 112, Taiwan.ORCID 0000-0001-5924-0066
National Yang Ming Chiao Tung University · TWFar Eastern Memorial Hospital · TWTaipei Veterans General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Muscle wasting, known to develop in patients with chronic kidney disease (CKD), is a deleterious consequence of numerous complications associated with deteriorated renal function. Muscle wasting in CKD mainly involves dysregulated muscle protein metabolism and impaired muscle cell regeneration. In this narrative review, we discuss the cardinal role of the insulin-like growth factor 1 and myostatin signaling pathways, which have been extensively investigated using animal and human studies, as well as the emerging concepts in microRNA- and gut microbiota-mediated regulation of muscle mass and myogenesis. To ameliorate muscle loss, therapeutic strategies, including nutritional support, exercise programs, pharmacological interventions, and physical modalities, are being increasingly developed based on advances in understanding its underlying pathophysiology.

Indexed as

Muscular DiseasesRenal Insufficiency, ChronicAnimalsHumansMuscle ProteinsMuscle, SkeletalMuscular AtrophyMuscle Proteinschronic kidney diseaseexercisemolecular mechanismmuscle regenerationmuscle wastingnutritionpharmaceutical interventionphysical modalityprotein metabolism

Identifiers

PMID35682722
PMCPMC9181340
OpenAlexW4281729335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.